DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Solèr M, Matz J, Townley R. , et al.
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics.
Eur Respir J 2001;
18 (02) 254-261
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.